Page 17 - EJMO-9-1
P. 17

Eurasian Journal of Medicine and
            Oncology
                                                                             Single-cell RNA-seq in malignant skin tumors


            to the early cellular response to therapy. Co-activating   and complex, posing challenges in bioinformatics for
            P2RX7 expression may enhance treatment efficacy and   efficiently and accurately extracting key information while
            delay resistance development. Another study using single-  eliminating interference. In addition, cells are dynamic
            cell technology discovered that only a small fraction of   entities; however, most current single-cell sequencing
            melanoma cells exhibit effective activation of receptor   technologies capture only a snapshot of the cell state at
            tyrosine kinase and extracellular signal-regulated kinase,   a specific moment. Therefore, there is a need to develop
            contributing to persistence.  This insight provides a non-  and explore technologies and algorithms that can capture
                                  82
            heritable mechanism for understanding the development   the dynamic changes of cells over time and across spatial
            of resistance to BRAF inhibitors combined with MEK   contexts.
            inhibitors treatment. The emergence of resistance is   The rapid development of single-cell sequencing
            multifactorial and complex. By leveraging single-cell   technology offers vast potential in cancer research.
            technology, researchers can gain a more comprehensive   Integrating single-cell sequencing with other omics
            understanding of the mechanisms underlying CM      technologies, such as single-cell proteomics, epigenomics,
            treatment resistance, providing robust support for   and spatial  transcriptomics,  enables  researchers  to gain
            personalized treatment approaches and the development   a more comprehensive understanding of tumor biology.
            of new therapeutic strategies (Table 3).           Spatial transcriptomics (ST) is a technology that studies

            6. Challenges and future prospects                 the expression and spatial relationships of specific genes
                                                               within tissues or cells, helping to comprehend the spatial
            Single-cell sequencing has significantly advanced the   heterogeneity of cell subtypes and gene expression
            study of skin tumors, unveiling various aspects such as   across different regions of tissues. Despite its relatively
            TME characteristics, mechanisms of disease progression,   short existence, ST plays a significant role in single-cell
            identification of new therapeutic targets, and changes   research. 85,86  Wang et al.  found that most methods achieve
                                                                                  87
            in the TME related to treatment efficacy. 83,84  However,   cell type decomposition by combining the expression of
            challenges persist due to technological limitations and data   cell type-specific genes, with the accuracy of these genes
            complexity. First, the efficiency of single-cell isolation and   relying  on  the  consistency  between  scRNA-seq  and  ST
            capture is crucial for accurate research outcomes. Changes   data. An instance-based transfer learning framework
            in cell adaptability and integrity during the isolation   that can reduce discrepancies between scRNA-seq and
            process, as well as cell omissions during capture, can lead to   ST data was developed, allowing for accurate matching
            misleading results. In addition, biases in selecting specific   of cell type-specific gene expression. In addition, Yang
            cell types, experimental errors introduced during sample   et al.  integrated single-cell transcriptomics and spatial
                                                                   88
            processing, and inherent interferences in the technology   transcriptomics to construct a high-resolution single-
            may affect subsequent analyses. On the other hand, the   cell atlas of renal cell carcinoma, dissecting its metabolic
            data generated by single-cell sequencing are often massive   heterogeneity across spatial locations. The Python package


            Table 3. Key studies associated with the use of single‑cell RNA sequencing in cutaneous melanoma
            Cancer  Cell origin  Properties   Authors                         Key findings
            type
            CM    Melanocytes High invasiveness and   Deng et al. 67  The exhaustion-associated subgroup 2 represented the terminal state of CD8
                           metastatic potential        T-cell differentiation, leading to poor prognosis, marker genes PMEL, TYRP1, and
                                                       EDNRB suggest potential novel therapeutic targets.
                                            Lian et al. 69  CEMIP and NKD1 fibroblast clusters in CM are closely associated with immune
                                                                    +
                                                            +
                                                       therapy resistance.
                                            Kim et al. 73  Single-cell sequencing analysis shows that CD244 significantly influences
                                                       phagocytosis, antigen presentation, and autophagy, suggesting CD244 deficient
                                                       macrophages could be an effective immunotherapy approach.
                                            Shi et al. 75  Patients with the ‘Immune-Hot/Active’ phenotype, characterized by more
                                                       non-regulated B cells, cytotoxic CD8 T-cells, and lower mixed states CD8 T-cells,
                                                       tend to respond better to anti-PD1 treatment.
                                            Capparelli et al. 79  Revealed a cross-resistance relationship between the SOX10-deficient cell subgroup
                                                       and targeted checkpoint inhibitors and immune checkpoint inhibitors, emphasizing
                                                       the significance of treating this subgroup.
            Abbreviation: CM: Cutaneous melanoma.


            Volume 9 Issue 1 (2025)                         9                               doi: 10.36922/ejmo.5809
   12   13   14   15   16   17   18   19   20   21   22